Applied Molecular Transport, Inc. is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment of autoimmune, inflammatory, and metabolic diseases. The company was founded by Tahir Mahmood on November 21, 2016 and is headquartered in South San Francisco, CA.

Shanghai Want Want Food Group Co., Ltd., established on 2001-12-12, Business scope includes entrusted by Want Want Holdings Co., Ltd.,for the companies it invests in:Investment and operation decision,Marketing Services,Fund Operation and Financial Management,Technical support and research and development,information service,Staff training and management;Wholesale of prepackaged food(branch only);software development.(Commodities that do not involve state trade management,Quota involved,of license-managed goods,Apply in accordance with relevant national regulations.) [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Develops vaccine

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Daewoong Pharmaceutical Co., Ltd (Korean: 대웅제약) is a Seoul, South Korea-based bioengineering company operating as a subsidiary of Daewoong Co., Ltd., a global health care group. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products in South Korea, including prescription and over-the-counter healthcare products.

MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. is a joint venture company headquartered in Gurgaon, India. The firm develops and researches vaccines. It was founded in 2009. Raman Rao has been the CEO since 2020.\nThe company says this about itself: Hilleman Laboratories was established as an equal joint venture by MSD and Wellcome Trust in 2009, headquartered in New Delhi, India. Hilleman Laboratories is a global vaccine R&D organization committed to developing high impact, affordable vaccines for low- and middle- income countries. Our translational research focuses on creating safe, low-cost vaccines and innovative delivery technologies that are highly effective and can be easily incorporated into immunization programs. Hilleman Lab��s focus is on transforming ideas into products and technologies through translational R&D and by building partnerships with global stakeholders and vaccine manufacturers.

Active Biotech AB engages in the development of pharmaceutical products. The firm specializes in the medical areas where the immune defense is of significant importance, including neurodegenerative diseases, autoimmune, inflammatory disease, and various forms of cancer. Its portfolio comprises orally active immunomodulatory molecules as well as antibody-based immunotherapy. The company was founded on June 15, 1982 and is headquartered in Lund, Sweden.

Sichuan Huahan Sanchuang Biotechnology Co., Ltd., established on 2013-12-23, Business scope includes biomedical technology research and development,technical consulting,technology transfer,Technology Promotion(No pre-licensed items,Post-licensing projects operate on the basis of licenses or approval documents);Medical Research and Experimental Development;Agricultural Science Research and Experimental Development;Natural science research and experimental development;research and development,Production(Restrict branches to operate in industrial parks),sales of biochemicals(Free of drugs and blood products)and instrumentation(Does not include measuring instruments).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

"Shanghai Chemtron Biotech Co., Ltd. is a global rapid diagnostic test manufacturer.Founded in 2001,Shanghai Chemtron Biotech Co. has been committed to manufacturing in vitro diagnostic test kits sold around the world.Chemtron has established business relationships with over 60 countries through Chemtron's test kits under the Chemtrue brand as well as OEM packing. Chemtron's manufacturing site is located in Shanghai, China and houses 130,000 square feet of state-of-the-art medical diagnostic test manufacturing space.Chemtron's US office is located in San Diego,California. Chemtron currently has ISO 13485:2012 certification.The majority of products are CE approved with some products being registered with FDA.Chemtron continues to improve its quality system in order to bring reliable and consistent products to their customers. With over 15 years of successful commercial manufacturing experience,Chemtron's dedicated team of scientists,engineers and technicians offer substantial labor anf overhead cost efficiencies."

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT’s proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Active transport is an efficient mechanism that uses the cell’s own machinery to transport materials across the IE barrier. AMT believes that its ability to exploit this mechanism is a key differentiator of its approach. AMT is developing oral biologic product candidates in patient-friendly tablet and capsule forms that are designed for either targeting local gastrointestinal (GI) tissue or entering systemic circulation to precisely address the relevant biology of a disease. AMT is building a portfolio of oral product candidates based on its technology platform including its lead product candidate, AMT-101, an oral GI-selective interleukin 10 that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). AMT further plans to initiate Phase 2 clinical trials of AMT-101 in UC and related inflammatory indications. AMT’s technology platform enables it to design and develop various oral biologic therapeutic modalities, such as peptides, proteins, full-length antibodies, antibody fragments, and RNA therapeutics, with potentially significant advantages over existing marketed and development-stage drugs.

TonenGeneral Sekiyu K.K. is a Japan-based company engaged in the import, transportation, refining, manufacture and sale of crude oil, petroleum products and petrochemical products, among others. The Company has two business segments. The Petroleum segment is engaged in the production, processing and sale of petroleum products, the transportation of crude oil and petroleum products, the purchase and sale of liquefied natural gas (LNG), the procurement and sale of biomass fuels, as well as the holding of shares. The Petrochemical Product segment is involved in the production, processing and sale of petrochemical products.

Kemin Industries, Inc. develops and manufactures nutritional ingredients. It operates through two business units: Animal Nutrition & Health and Food & Human. The Animal Nutrition & Health business unit offers products that provide nutrition and health benefits for animals. The business unit?s products include ButiPEARL, ButiPEARL Z, CholiPEARL, CLOSTAT, ENDOX and FRESH CUT Plus. The Food & Human business unit offers products that benefits human health. The business unit?s products include AssuriTEA, FloraGLO, Neumentix, Slendesta and XSurge. The firm manufactures specialty ingredients for the global feed and food industries as well as the health, nutrition and beauty markets. The company operates offices and manufacturing facilities in Asia Pacific, China, EMEA, India, North America and South America regions. Kemin Industries was founded by Rolland W. Nelson and Mary Ann Nelson in 1961 and is headquartered in Des Moines, IA.

Nanjing Tianbang Bio Technology Co., Ltd., part of Beijing Dabeinong Technology Group Co., Ltd., is a Chinese company located in Nanjing. The firm engages in researching and developing animal bio products. On March 12, 2014 Beijing Dabeinong Technology Group Co., Ltd. acquired Nanjing Tianbang Bio Technology Co., Ltd. for $1.94 million.

Bioyong Technology, Inc. (doing business as Beijing Yi Xinbo Chuang Biotechnology Co., Ltd.) is a Chinese private company located in Changping. The firm develops mass spectrometry technologies.

SBL Vaccin AB manufactures and distributes vaccines. Its products are used for the treatment of polio, diarrhoea, and cholera diseases. The company distributes products to the healthcare centers, hospitals, schools, and industrial healthcare units. SBL Vaccin was founded in 1957 and is located in Solna, Sweden.

Zhaofenghua Biotechnology (Fuzhou) Co., Ltd., established on 2003-05-26, Business scope includes technical development of biological products,Technical Services,Technology Transfer and Technology Consulting;Medical Research and Experimental Development;Agricultural Science Research and Experimental Development;Biopharmaceutical Manufacturing;Genetically engineered drugs and vaccine manufacturing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)